JG
TARO

Jefferies Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Jefferies Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,292
Closed -$267K – 2651
2017
Q1 		$267K Hold
2,292
– – ﹤0.01% 1882
2016
Q4 		$241K Buy
+2,292
New +$240K ﹤0.01% 1841
2016
Q1 		– Sell
-2,227
Closed -$344K – 2648
2015
Q4 		$344K Buy
+2,227
New +$325K ﹤0.01% 1722

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jefferies Group's TARO Position: Q2 2017 in Review

Jefferies Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2017, closing a stake of 2,292 shares — an estimated $267K sold.

Jefferies Group first reported a position in TARO in Q4 2015 and held it in 3 quarters. The position peaked at $344K in Q4 2015. 140 funds tracked by Wall St. Rank hold TARO as of Q2 2017.

  • Jefferies Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2017 after selling out during the quarter.
  • Jefferies Group sold 2,292 Taro Pharmaceutical Industries Ltd. shares in Q2 2017, an estimated $267K.
  • Jefferies Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 3 quarters.
  • Jefferies Group's Taro Pharmaceutical Industries Ltd. position peaked at $344K in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2017.

Based on Jefferies Group's 13F filing for Q2 2017, filed 14 Aug 2017.